Sixteen-week multicentre randomised controlled trial to study the effect of the consumption of an oat beta-glucan-enriched bread versus a whole-grain wheat bread on glycaemic control among persons with pre-diabetes: a study protocol of the CarbHealth study

Therese Hjorth, Alena Schadow, Ingrid Revheim, Ulrike Spielau, Lise M Thomassen, Klara Meyer, Katja Piotrowski, Hanne Rosendahl-Riise, Anne Rieder, Paula Varela, Vegard Lysne, Simon Ballance, Antje Koerner, Rikard Landberg, Anette Buyken, Jutta Dierkes, Therese Hjorth, Alena Schadow, Ingrid Revheim, Ulrike Spielau, Lise M Thomassen, Klara Meyer, Katja Piotrowski, Hanne Rosendahl-Riise, Anne Rieder, Paula Varela, Vegard Lysne, Simon Ballance, Antje Koerner, Rikard Landberg, Anette Buyken, Jutta Dierkes

Abstract

Introduction: In 2012, the estimated global prevalence of pre-diabetes was 280 million, and the prevalence is expected to rise to 400 million by 2030. Oat-based foods are a good source of beta-glucans, which have been shown to lower postprandial blood glucose. Studies to evaluate the effectiveness of the long-term intake of beta-glucan-enriched bread as part of a habitual diet among individuals with pre-diabetes are needed. Therefore, we designed a multicentre intervention study in adults with pre-diabetes to investigate the effects of consumption of an oat-derived beta-glucan-enriched bread as part of a normal diet on glycated haemoglobin (HbA1c) in comparison to consumption of whole-grain wheat bread.

Methods and analysis: The CarbHealth trial is a multicentre double-blind randomised controlled 16-week dietary intervention trial in participants 40-70 years of age with a body mass index of ≥27 kg/m2 and HbA1c of 35-50 mmol/mol. The study is conducted at four universities located in Norway, Sweden and Germany and uses intervention breads specifically designed for the trial by Nofima AS. The aim is to recruit 250 participants. The primary outcome is the difference in HbA1c between the intervention and the control groups. The main analysis will include intervention group, study centre and baseline HbA1c as independent variables in an analysis of covariance model.

Ethics and dissemination: The study protocol was approved by respective ethical authorities in participating countries. The results of the study will be communicated through publication in international scientific journals and presentations at (inter)national conferences.

Trial registration number: NCT04994327.

Keywords: Clinical trials; General diabetes; PUBLIC HEALTH.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flowchart of the study visits in the CarbHealth multicentre study.

References

    1. Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 2015;6:1246–58. 10.4239/wjd.v6.i13.1246
    1. Saeedi P, Petersohn I, Salpea P. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International diabetes Federation diabetes atlas. 157. 9th ed. Diabetes Research and Clinical Practice, 2019: 107843.
    1. Perreault L, Færch K. Approaching pre-diabetes. J Diabetes Complications 2014;28:226–33. 10.1016/j.jdiacomp.2013.10.008
    1. World Health Organization WHO . Diabetes, 2020. Available: [Accessed 28 Sept 2020].
    1. International Expert Committee . International expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34. 10.2337/dc09-9033
    1. International Diabetes Federation IDF . IDF diabetes atlas, 2017. 8th ed, 2017.
    1. Wang YC, McPherson K, Marsh T, et al. . Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378:815–25. 10.1016/S0140-6736(11)60814-3
    1. Ley SH, Hamdy O, Mohan V, et al. . Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 2014;383:1999–2007. 10.1016/S0140-6736(14)60613-9
    1. Poutanen KS, Kårlund AO, Gómez-Gallego C, et al. . Grains – a major source of sustainable protein for health. Nutr Rev 2022;80:1648–63. 10.1093/nutrit/nuab084
    1. Reynolds A, Mann J, Cummings J, et al. . Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 2019;393:434–45. 10.1016/S0140-6736(18)31809-9
    1. Ludwig DS, Hu FB, Tappy L, et al. . Dietary carbohydrates: role of quality and quantity in chronic disease. BMJ 2018;361:k2340. 10.1136/bmj.k2340
    1. Pick ME, Hawrysh ZJ, Gee MI, et al. . Barley bread products improve glycemic control of type 2 subjects. Int J Food Sci Nutr 1998;49:71–8. 10.3109/09637489809086406
    1. Östman EM, Frid AH, Groop LC, et al. . A dietary exchange of common bread for tailored bread of low glycaemic index and rich in dietary fibre improved insulin economy in young women with impaired glucose tolerance. Eur J Clin Nutr 2006;60:334–41. 10.1038/sj.ejcn.1602319
    1. Tessari P, Lante A. A multifunctional bread rich in beta glucans and low in starch improves metabolic control in type 2 diabetes: a controlled trial. Nutrients 2017;9. 10.3390/nu9030297. [Epub ahead of print: 17 Mar 2017].
    1. Cicero AFG, Fogacci F, Veronesi M, et al. . A randomized placebo-controlled clinical trial to evaluate the medium-term effects of oat fibers on human health: the beta-glucan effects on lipid profile, glycemia and inTestinal health (belt) study. Nutrients 2020;12. 10.3390/nu12030686. [Epub ahead of print: 03 Mar 2020].
    1. Williams B, Mancia G, Spiering W. ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of cardiology (ESC) and the European Society of hypertension (ESH). Eur Heart J 2018;39:3021–104. 10.1093/eurheartj/ehy339
    1. Koch SAJ, Conrad J, Cade JE, et al. . Validation of the web-based self-administered 24-h dietary recall myfood24-Germany: comparison with a weighed dietary record and biomarkers. Eur J Nutr 2021;60:4069–82. 10.1007/s00394-021-02547-7
    1. Koch SAJ, Conrad J, Hierath L, et al. . Adaptation and evaluation of Myfood24-Germany: a web-based self-administered 24-h dietary recall for the German adult population. Nutrients 2020;12. 10.3390/nu12010160. [Epub ahead of print: 06 Jan 2020].
    1. Salvesen L, Engeset D, Øverby NC, et al. . Development and evaluation of image-series for portion size estimation in dietary assessment among adults. J Nutr Sci 2021;10:e3. 10.1017/jns.2020.58
    1. Nguyen QC, Wahlgren MB, Almli VL, et al. . Understanding the role of dynamic texture perception in consumers’ expectations of satiety and satiation. A case study on barley bread. Food Qual Prefer 2017;62:218–26. 10.1016/j.foodqual.2017.06.006
    1. Varela P, Ares G, profiling S. Sensory profiling, the blurred line between sensory and consumer science. A review of novel methods for product characterization. Food Res Int 2012;48:893–908. 10.1016/j.foodres.2012.06.037
    1. Craig CL, Marshall AL, Sjöström M, et al. . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95. 10.1249/01.MSS.0000078924.61453.FB
    1. Roenneberg T, Wirz-Justice A, Merrow M. Life between clocks: daily temporal patterns of human chronotypes. J Biol Rhythms 2003;18:80–90. 10.1177/0748730402239679
    1. Jakobsen JC, Gluud C, Wetterslev J, et al. . When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol 2017;17:162. 10.1186/s12874-017-0442-1
    1. Cole RE, Boyer KM, Spanbauer SM, et al. . Effectiveness of prediabetes nutrition shared medical appointments: prevention of diabetes. Diabetes Educ 2013;39:344–53. 10.1177/0145721713484812
    1. Shepherd R, Shepherd R. Resistance to changes in diet. Proc Nutr Soc 2002;61:267–72. 10.1079/PNS2002147
    1. Goletzke J, Atkinson FS, Ek KL, et al. . Glycaemic and insulin index of four common German breads. Eur J Clin Nutr 2016;70:808–11. 10.1038/ejcn.2016.9
    1. Tuomilehto J, Lindström J, Eriksson JG, et al. . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50. 10.1056/NEJM200105033441801
    1. Kroeger CM, Garza C, Lynch CJ, et al. . Scientific rigor and credibility in the nutrition research landscape. Am J Clin Nutr 2018;107:484–94. 10.1093/ajcn/nqx067
    1. Vorland CJ, Brown AW, Dawson JA, et al. . Errors in the implementation, analysis, and reporting of randomization within obesity and nutrition research: a guide to their avoidance. Int J Obes 2021;45:2335–46. 10.1038/s41366-021-00909-z
    1. Rieder A, Knutsen SH, Sainz Fernandez A, et al. . At a high dose even partially degraded beta-glucan with decreased solubility significantly reduced the glycaemic response to bread. Food Funct 2019;10:1529–39. 10.1039/C8FO02098A

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera